Are GLP-1 Results Permanent or Do You Gain the Weight Back
While certainly not outweighing the good these medications offer, prescribing physicians need to keep in mind the real and serious ocular adverse events that may occur. A spokesperson for Novo Nordisk, which manufactures Ozempic and Wegovy, said: Patient safety is our top priority and we take any report about an adverse event related to the use of our medicines very seriously
In women with polycystic ovary syndrome and elevated testosterone, semaglutide-related weight loss typically reduces androgen levels beneficially, improving symptoms like irregular periods and hirsutism
The relationship between weight and blood pressure operates through mechanical and metabolic channels
Not yet commercially available Retatrutide is currently in Phase 3 clinical trials and has not yet received regulatory approval for commercial prescribing in the UK
Additionally, it slows down gastric emptying, prolonging the feeling of fullness and reducing the urge to overeat